APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Selected research

Market Analysis & Forecast

Global Enoxaparin Sodium Market Analysis and Forecast 2026-2032

30 December 2025217 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.

There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.

Read the full market overview

This report presents an overview of global market for Enoxaparin Sodium, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enoxaparin Sodium, also provides the sales of main regions and countries. Of the upcoming market potential for Enoxaparin Sodium, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enoxaparin Sodium sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enoxaparin Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Enoxaparin Sodium sales, projected growth trends, production technology, application and end-user industry.

Enoxaparin Sodium Segment by Company

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

Huadong Medicine

Bharat Serums

INTAS

LUPIN

Troikaa Pharmaceuticals

Aristopharma

Fosun Pharma

SciencePharma

PISA

Enoxaparin Sodium Segment by Type

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Enoxaparin Sodium Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Enoxaparin Sodium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enoxaparin Sodium sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enoxaparin Sodium Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 20 mg/0.2mL Major Manufacturers Table 3. 30 mg/0.3mL Major Manufacturers Table 4. 40 mg/0.4mL Major Manufacturers Table 5. 60 mg/0.6mL Major Manufacturers Table 6. 80 mg/0.8mL Major Manufacturers Table 7. 100 mg/1mL Major Manufacturers Table 8. 120 mg/0.8mL Major Manufacturers Table 9. 150 mg/1mL Major Manufacturers Table 10. 300mg/3mL Major Manufacturers Table 11. Global Enoxaparin Sodium Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Hospital Major Manufacturers Table 13. Clinic Major Manufacturers Table 14. Others Major Manufacturers Table 15. Enoxaparin Sodium Industry Trends Table 16. Enoxaparin Sodium Industry Drivers Table 17. Enoxaparin Sodium Industry Opportunities and Challenges Table 18. Enoxaparin Sodium Industry Restraints Table 19. Global Enoxaparin Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Enoxaparin Sodium Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Enoxaparin Sodium Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Enoxaparin Sodium Revenue Market Share by Region (2021-2026) Table 23. Global Enoxaparin Sodium Revenue Market Share by Region (2027-2032) Table 24. Global Enoxaparin Sodium Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 25. Global Enoxaparin Sodium Sales by Region (2021-2026) & (M Units) Table 26. Global Enoxaparin Sodium Sales by Region (2027-2032) & (M Units) Table 27. Global Enoxaparin Sodium Sales Market Share by Region (2021-2026) Table 28. Global Enoxaparin Sodium Sales Market Share by Region (2027-2032) Table 29. Global Enoxaparin Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Enoxaparin Sodium Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2021-2026) Table 33. Global Enoxaparin Sodium Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Enoxaparin Sodium Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Enoxaparin Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Enoxaparin Sodium Manufacturers, Product Type & Application Table 37. Global Enoxaparin Sodium Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Enoxaparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Enoxaparin Sodium Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Enoxaparin Sodium Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Enoxaparin Sodium Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Enoxaparin Sodium Revenue Market Share by Type (2021-2026) Table 44. Global Enoxaparin Sodium Revenue Market Share by Type (2027-2032) Table 45. Global Enoxaparin Sodium Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 46. Global Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 47. Global Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 48. Global Enoxaparin Sodium Sales Market Share by Type (2021-2026) Table 49. Global Enoxaparin Sodium Sales Market Share by Type (2027-2032) Table 50. Global Enoxaparin Sodium Price by Type (2021-2026) & (US$/Unit) Table 51. Global Enoxaparin Sodium Price by Type (2027-2032) & (US$/Unit) Table 52. Global Enoxaparin Sodium Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Enoxaparin Sodium Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Enoxaparin Sodium Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Enoxaparin Sodium Revenue Market Share by Application (2021-2026) Table 56. Global Enoxaparin Sodium Revenue Market Share by Application (2027-2032) Table 57. Global Enoxaparin Sodium Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 58. Global Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 59. Global Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 60. Global Enoxaparin Sodium Sales Market Share by Application (2021-2026) Table 61. Global Enoxaparin Sodium Sales Market Share by Application (2027-2032) Table 62. Global Enoxaparin Sodium Price by Application (2021-2026) & (US$/Unit) Table 63. Global Enoxaparin Sodium Price by Application (2027-2032) & (US$/Unit) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Enoxaparin Sodium Product Portfolio Table 68. Sanofi Recent Development Table 69. Teva Company Information Table 70. Teva Business Overview Table 71. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Teva Enoxaparin Sodium Product Portfolio Table 73. Teva Recent Development Table 74. Techdow (Hepalink) Company Information Table 75. Techdow (Hepalink) Business Overview Table 76. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio Table 78. Techdow (Hepalink) Recent Development Table 79. Fresenius Kabi Company Information Table 80. Fresenius Kabi Business Overview Table 81. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Fresenius Kabi Enoxaparin Sodium Product Portfolio Table 83. Fresenius Kabi Recent Development Table 84. Rovi Company Information Table 85. Rovi Business Overview Table 86. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Rovi Enoxaparin Sodium Product Portfolio Table 88. Rovi Recent Development Table 89. Amphastar Company Information Table 90. Amphastar Business Overview Table 91. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Amphastar Enoxaparin Sodium Product Portfolio Table 93. Amphastar Recent Development Table 94. Nanjing King-friend Company Information Table 95. Nanjing King-friend Business Overview Table 96. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nanjing King-friend Enoxaparin Sodium Product Portfolio Table 98. Nanjing King-friend Recent Development Table 99. Sandoz Company Information Table 100. Sandoz Business Overview Table 101. Sandoz Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sandoz Enoxaparin Sodium Product Portfolio Table 103. Sandoz Recent Development Table 104. Apotex Company Information Table 105. Apotex Business Overview Table 106. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Apotex Enoxaparin Sodium Product Portfolio Table 108. Apotex Recent Development Table 109. Hangzhou Jiuyuan Gene Engineering Company Information Table 110. Hangzhou Jiuyuan Gene Engineering Business Overview Table 111. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio Table 113. Hangzhou Jiuyuan Gene Engineering Recent Development Table 114. Cipla Company Information Table 115. Cipla Business Overview Table 116. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Cipla Enoxaparin Sodium Product Portfolio Table 118. Cipla Recent Development Table 119. Taj Pharma Company Information Table 120. Taj Pharma Business Overview Table 121. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Taj Pharma Enoxaparin Sodium Product Portfolio Table 123. Taj Pharma Recent Development Table 124. Chengdu Baiyu Pharmaceutical Company Information Table 125. Chengdu Baiyu Pharmaceutical Business Overview Table 126. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio Table 128. Chengdu Baiyu Pharmaceutical Recent Development Table 129. Suzhou Erye Pharmaceutical Company Information Table 130. Suzhou Erye Pharmaceutical Business Overview Table 131. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio Table 133. Suzhou Erye Pharmaceutical Recent Development Table 134. Changzhou Qianhong Bio-pharma Company Information Table 135. Changzhou Qianhong Bio-pharma Business Overview Table 136. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio Table 138. Changzhou Qianhong Bio-pharma Recent Development Table 139. Hebei Changshan Biochemical Pharmaceutical Company Information Table 140. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 141. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio Table 143. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 144. Beijing SL Pharmaceutical Company Information Table 145. Beijing SL Pharmaceutical Business Overview Table 146. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio Table 148. Beijing SL Pharmaceutical Recent Development Table 149. Huadong Medicine Company Information Table 150. Huadong Medicine Business Overview Table 151. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Huadong Medicine Enoxaparin Sodium Product Portfolio Table 153. Huadong Medicine Recent Development Table 154. Bharat Serums Company Information Table 155. Bharat Serums Business Overview Table 156. Bharat Serums Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Bharat Serums Enoxaparin Sodium Product Portfolio Table 158. Bharat Serums Recent Development Table 159. INTAS Company Information Table 160. INTAS Business Overview Table 161. INTAS Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. INTAS Enoxaparin Sodium Product Portfolio Table 163. INTAS Recent Development Table 164. LUPIN Company Information Table 165. LUPIN Business Overview Table 166. LUPIN Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. LUPIN Enoxaparin Sodium Product Portfolio Table 168. LUPIN Recent Development Table 169. Troikaa Pharmaceuticals Company Information Table 170. Troikaa Pharmaceuticals Business Overview Table 171. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio Table 173. Troikaa Pharmaceuticals Recent Development Table 174. Aristopharma Company Information Table 175. Aristopharma Business Overview Table 176. Aristopharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Aristopharma Enoxaparin Sodium Product Portfolio Table 178. Aristopharma Recent Development Table 179. Fosun Pharma Company Information Table 180. Fosun Pharma Business Overview Table 181. Fosun Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Fosun Pharma Enoxaparin Sodium Product Portfolio Table 183. Fosun Pharma Recent Development Table 184. SciencePharma Company Information Table 185. SciencePharma Business Overview Table 186. SciencePharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. SciencePharma Enoxaparin Sodium Product Portfolio Table 188. SciencePharma Recent Development Table 189. PISA Company Information Table 190. PISA Business Overview Table 191. PISA Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 192. PISA Enoxaparin Sodium Product Portfolio Table 193. PISA Recent Development Table 194. North America Enoxaparin Sodium Revenue by Type (2021-2026) & (US$ Million) Table 195. North America Enoxaparin Sodium Revenue by Type (2027-2032) & (US$ Million) Table 196. North America Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 197. North America Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 198. North America Enoxaparin Sodium Sales Price by Type (2021-2026) & (US$/Unit) Table 199. North America Enoxaparin Sodium Sales Price by Type (2027-2032) & (US$/Unit) Table 200. North America Enoxaparin Sodium Revenue by Application (2021-2026) & (US$ Million) Table 201. North America Enoxaparin Sodium Revenue by Application (2027-2032) & (US$ Million) Table 202. North America Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 203. North America Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 204. North America Enoxaparin Sodium Sales Price by Application (2021-2026) & (US$/Unit) Table 205. North America Enoxaparin Sodium Sales Price by Application (2027-2032) & (US$/Unit) Table 206. North America Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. North America Enoxaparin Sodium Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. North America Enoxaparin Sodium Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. North America Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 210. North America Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 211. North America Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 212. North America Enoxaparin Sodium Sales Price by Country (2021-2026) & (US$/Unit) Table 213. North America Enoxaparin Sodium Sales Price by Country (2027-2032) & (US$/Unit) Table 214. United States Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 215. Canada Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 216. Mexico Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 217. Europe Enoxaparin Sodium Revenue by Type (2021-2026) & (US$ Million) Table 218. Europe Enoxaparin Sodium Revenue by Type (2027-2032) & (US$ Million) Table 219. Europe Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 220. Europe Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 221. Europe Enoxaparin Sodium Sales Price by Type (2021-2026) & (US$/Unit) Table 222. Europe Enoxaparin Sodium Sales Price by Type (2027-2032) & (US$/Unit) Table 223. Europe Enoxaparin Sodium Revenue by Application (2021-2026) & (US$ Million) Table 224. Europe Enoxaparin Sodium Revenue by Application (2027-2032) & (US$ Million) Table 225. Europe Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 226. Europe Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 227. Europe Enoxaparin Sodium Sales Price by Application (2021-2026) & (US$/Unit) Table 228. Europe Enoxaparin Sodium Sales Price by Application (2027-2032) & (US$/Unit) Table 229. Europe Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. Europe Enoxaparin Sodium Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. Europe Enoxaparin Sodium Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. Europe Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 233. Europe Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 234. Europe Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 235. Europe Enoxaparin Sodium Sales Price by Country (2021-2026) & (US$/Unit) Table 236. Europe Enoxaparin Sodium Sales Price by Country (2027-2032) & (US$/Unit) Table 237. Germany Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 238. France Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 239. U.K. Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 240. Italy Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 241. Russia Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 242. Spain Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 243. Netherlands Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 244. Switzerland Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 245. Sweden Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 246. Poland Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 247. China Enoxaparin Sodium Revenue by Type (2021-2026) & (US$ Million) Table 248. China Enoxaparin Sodium Revenue by Type (2027-2032) & (US$ Million) Table 249. China Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 250. China Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 251. China Enoxaparin Sodium Sales Price by Type (2021-2026) & (US$/Unit) Table 252. China Enoxaparin Sodium Sales Price by Type (2027-2032) & (US$/Unit) Table 253. China Enoxaparin Sodium Revenue by Application (2021-2026) & (US$ Million) Table 254. China Enoxaparin Sodium Revenue by Application (2027-2032) & (US$ Million) Table 255. China Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 256. China Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 257. China Enoxaparin Sodium Sales Price by Application (2021-2026) & (US$/Unit) Table 258. China Enoxaparin Sodium Sales Price by Application (2027-2032) & (US$/Unit) Table 259. Asia Enoxaparin Sodium Revenue by Type (2021-2026) & (US$ Million) Table 260. Asia Enoxaparin Sodium Revenue by Type (2027-2032) & (US$ Million) Table 261. Asia Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 262. Asia Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 263. Asia Enoxaparin Sodium Sales Price by Type (2021-2026) & (US$/Unit) Table 264. Asia Enoxaparin Sodium Sales Price by Type (2027-2032) & (US$/Unit) Table 265. Asia Enoxaparin Sodium Revenue by Application (2021-2026) & (US$ Million) Table 266. Asia Enoxaparin Sodium Revenue by Application (2027-2032) & (US$ Million) Table 267. Asia Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 268. Asia Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 269. Asia Enoxaparin Sodium Sales Price by Application (2021-2026) & (US$/Unit) Table 270. Asia Enoxaparin Sodium Sales Price by Application (2027-2032) & (US$/Unit) Table 271. Asia Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 272. Asia Enoxaparin Sodium Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 273. Asia Enoxaparin Sodium Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 274. Asia Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 275. Asia Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 276. Asia Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 277. Asia Enoxaparin Sodium Sales Price by Country (2021-2026) & (US$/Unit) Table 278. Asia Enoxaparin Sodium Sales Price by Country (2027-2032) & (US$/Unit) Table 279. Japan Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 280. South Korea Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 281. India Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 282. Australia Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 283. Taiwan Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 284. Southeast Asia Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 285. SAMEA Enoxaparin Sodium Revenue by Type (2021-2026) & (US$ Million) Table 286. SAMEA Enoxaparin Sodium Revenue by Type (2027-2032) & (US$ Million) Table 287. SAMEA Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 288. SAMEA Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 289. SAMEA Enoxaparin Sodium Sales Price by Type (2021-2026) & (US$/Unit) Table 290. SAMEA Enoxaparin Sodium Sales Price by Type (2027-2032) & (US$/Unit) Table 291. SAMEA Enoxaparin Sodium Revenue by Application (2021-2026) & (US$ Million) Table 292. SAMEA Enoxaparin Sodium Revenue by Application (2027-2032) & (US$ Million) Table 293. SAMEA Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 294. SAMEA Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 295. SAMEA Enoxaparin Sodium Sales Price by Application (2021-2026) & (US$/Unit) Table 296. SAMEA Enoxaparin Sodium Sales Price by Application (2027-2032) & (US$/Unit) Table 297. SAMEA Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 298. SAMEA Enoxaparin Sodium Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 299. SAMEA Enoxaparin Sodium Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 300. SAMEA Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 301. SAMEA Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 302. SAMEA Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 303. SAMEA Enoxaparin Sodium Sales Price by Country (2021-2026) & (US$/Unit) Table 304. SAMEA Enoxaparin Sodium Sales Price by Country (2027-2032) & (US$/Unit) Table 305. Brazil Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 306. Argentina Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 307. Chile Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 308. Colombia Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 309. Peru Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 310. Saudi Arabia Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 311. Israel Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 312. UAE Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 313. Turkey Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 314. Iran Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 315. Egypt Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Table 316. Key Raw Materials Table 317. Raw Materials Key Suppliers Table 318. Enoxaparin Sodium Distributors List Table 319. Enoxaparin Sodium Customers List Table 320. Research Programs/Design for This Report Table 321. Authors List of This Report Table 322. Secondary Sources Table 323. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Image Figure 2. Global Enoxaparin Sodium Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Market Size Share 2021 VS 2025 VS 2032 Figure 4. 20 mg/0.2mL Image Figure 5. 30 mg/0.3mL Image Figure 6. 40 mg/0.4mL Image Figure 7. 60 mg/0.6mL Image Figure 8. 80 mg/0.8mL Image Figure 9. 100 mg/1mL Image Figure 10. 120 mg/0.8mL Image Figure 11. 150 mg/1mL Image Figure 12. 300mg/3mL Image Figure 13. Global Enoxaparin Sodium Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Enoxaparin Sodium Market Size Share 2021 VS 2025 VS 2032 Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Enoxaparin Sodium Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Figure 20. Global Enoxaparin Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Enoxaparin Sodium Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Enoxaparin Sodium Revenue Market Share by Region (2021-2032) Figure 23. Global Enoxaparin Sodium Sales (2021-2032) & (M Units) Figure 24. Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 25. Global Enoxaparin Sodium Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Enoxaparin Sodium Sales YoY (2021-2032) & (M Units) Figure 27. Europe Enoxaparin Sodium Sales YoY (2021-2032) & (M Units) Figure 28. China Enoxaparin Sodium Sales YoY (2021-2032) & (M Units) Figure 29. Asia (Excluding China) Enoxaparin Sodium Sales YoY (2021-2032) & (M Units) Figure 30. South America, Middle East and Africa Enoxaparin Sodium Sales YoY (2021-2032) & (M Units) Figure 31. Global Enoxaparin Sodium Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Enoxaparin Sodium Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Enoxaparin Sodium Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Enoxaparin Sodium Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Enoxaparin Sodium Revenue Market Share by Type (2021-2032) Figure 37. Global Enoxaparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 38. Global Enoxaparin Sodium Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Enoxaparin Sodium Sales Market Share by Type (2021-2032) Figure 40. Global Enoxaparin Sodium Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Enoxaparin Sodium Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Enoxaparin Sodium Revenue Market Share by Application (2021-2032) Figure 43. Global Enoxaparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 44. Global Enoxaparin Sodium Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Enoxaparin Sodium Sales Market Share by Application (2021-2032) Figure 46. North America Enoxaparin Sodium Revenue Share by Type (2021-2032) Figure 47. North America Enoxaparin Sodium Sales Share by Type (2021-2032) Figure 48. North America Enoxaparin Sodium Revenue Share by Application (2021-2032) Figure 49. North America Enoxaparin Sodium Sales Share by Application (2021-2032) Figure 50. North America Enoxaparin Sodium Revenue Share by Country (2021-2032) Figure 51. North America Enoxaparin Sodium Sales Share by Country (2021-2032) Figure 52. Europe Enoxaparin Sodium Revenue Share by Type (2021-2032) Figure 53. Europe Enoxaparin Sodium Sales Share by Type (2021-2032) Figure 54. Europe Enoxaparin Sodium Revenue Share by Application (2021-2032) Figure 55. Europe Enoxaparin Sodium Sales Share by Application (2021-2032) Figure 56. Europe Enoxaparin Sodium Revenue Share by Country (2021-2032) Figure 57. Europe Enoxaparin Sodium Sales Share by Country (2021-2032) Figure 58. China Enoxaparin Sodium Revenue Share by Type (2021-2032) Figure 59. China Enoxaparin Sodium Sales Share by Type (2021-2032) Figure 60. China Enoxaparin Sodium Revenue Share by Application (2021-2032) Figure 61. China Enoxaparin Sodium Sales Share by Application (2021-2032) Figure 62. Asia Enoxaparin Sodium Revenue Share by Type (2021-2032) Figure 63. Asia Enoxaparin Sodium Sales Share by Type (2021-2032) Figure 64. Asia Enoxaparin Sodium Revenue Share by Application (2021-2032) Figure 65. Asia Enoxaparin Sodium Sales Share by Application (2021-2032) Figure 66. Asia Enoxaparin Sodium Revenue Share by Country (2021-2032) Figure 67. Asia Enoxaparin Sodium Sales Share by Country (2021-2032) Figure 68. SAMEA Enoxaparin Sodium Revenue Share by Type (2021-2032) Figure 69. SAMEA Enoxaparin Sodium Sales Share by Type (2021-2032) Figure 70. SAMEA Enoxaparin Sodium Revenue Share by Application (2021-2032) Figure 71. SAMEA Enoxaparin Sodium Sales Share by Application (2021-2032) Figure 72. SAMEA Enoxaparin Sodium Revenue Share by Country (2021-2032) Figure 73. SAMEA Enoxaparin Sodium Sales Share by Country (2021-2032) Figure 74. Enoxaparin Sodium Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Enoxaparin Sodium Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Teva
  • Techdow (Hepalink)
  • Fresenius Kabi
  • Rovi
  • Amphastar
  • Nanjing King-friend
  • Sandoz
  • Apotex
  • Hangzhou Jiuyuan Gene Engineering
  • Cipla
  • Taj Pharma
  • Chengdu Baiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Changzhou Qianhong Bio-pharma
  • Hebei Changshan Biochemical Pharmaceutical
  • Beijing SL Pharmaceutical
  • Huadong Medicine
  • Bharat Serums
  • INTAS
  • LUPIN
  • Troikaa Pharmaceuticals
  • Aristopharma
  • Fosun Pharma
  • SciencePharma
  • PISA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enoxaparin Sodium Market by Type
  3. 1.2.1 Global Enoxaparin Sodium Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 20 mg/0.2mL
  5. 1.2.3 30 mg/0.3mL
  6. 1.2.4 40 mg/0.4mL
  7. 1.2.5 60 mg/0.6mL
  8. 1.2.6 80 mg/0.8mL
  9. 1.2.7 100 mg/1mL
  10. 1.2.8 120 mg/0.8mL
  11. 1.2.9 150 mg/1mL
  12. 1.2.10 300mg/3mL
  13. 1.3 Enoxaparin Sodium Market by Application
  14. 1.3.1 Global Enoxaparin Sodium Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Hospital
  16. 1.3.3 Clinic
  17. 1.3.4 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Enoxaparin Sodium Market Dynamics
  1. 2.1 Enoxaparin Sodium Industry Trends
  2. 2.2 Enoxaparin Sodium Industry Drivers
  3. 2.3 Enoxaparin Sodium Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Enoxaparin Sodium Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Enoxaparin Sodium Revenue by Region
  3. 3.2.1 Global Enoxaparin Sodium Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enoxaparin Sodium Revenue by Region (2021-2026)
  5. 3.2.3 Global Enoxaparin Sodium Revenue by Region (2027-2032)
  6. 3.2.4 Global Enoxaparin Sodium Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Enoxaparin Sodium Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Enoxaparin Sodium Sales by Region
  9. 3.4.1 Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Enoxaparin Sodium Sales by Region (2021-2026)
  11. 3.4.3 Global Enoxaparin Sodium Sales by Region (2027-2032)
  12. 3.4.4 Global Enoxaparin Sodium Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Enoxaparin Sodium Revenue by Manufacturers
  2. 4.1.1 Global Enoxaparin Sodium Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Enoxaparin Sodium Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enoxaparin Sodium Sales by Manufacturers
  6. 4.2.1 Global Enoxaparin Sodium Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Enoxaparin Sodium Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Enoxaparin Sodium Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Enoxaparin Sodium Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Enoxaparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Enoxaparin Sodium Manufacturers, Product Type & Application
  13. 4.7 Global Enoxaparin Sodium Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Enoxaparin Sodium Market CR5 and HHI
  16. 4.8.2 2025 Enoxaparin Sodium Tier 1, Tier 2, and Tier 3
5 Enoxaparin Sodium Market by Type
  1. 5.1 Global Enoxaparin Sodium Revenue by Type
  2. 5.1.1 Global Enoxaparin Sodium Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Enoxaparin Sodium Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Enoxaparin Sodium Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Enoxaparin Sodium Sales by Type
  6. 5.2.1 Global Enoxaparin Sodium Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enoxaparin Sodium Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Enoxaparin Sodium Sales Market Share by Type (2021-2032)
  9. 5.3 Global Enoxaparin Sodium Price by Type
6 Enoxaparin Sodium Market by Application
  1. 6.1 Global Enoxaparin Sodium Revenue by Application
  2. 6.1.1 Global Enoxaparin Sodium Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Enoxaparin Sodium Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Enoxaparin Sodium Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Enoxaparin Sodium Sales by Application
  6. 6.2.1 Global Enoxaparin Sodium Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Enoxaparin Sodium Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Enoxaparin Sodium Sales Market Share by Application (2021-2032)
  9. 6.3 Global Enoxaparin Sodium Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Enoxaparin Sodium Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Enoxaparin Sodium Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Techdow (Hepalink)
  14. 7.3.1 Techdow (Hepalink) Company Information
  15. 7.3.2 Techdow (Hepalink) Business Overview
  16. 7.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
  18. 7.3.5 Techdow (Hepalink) Recent Developments
  19. 7.4 Fresenius Kabi
  20. 7.4.1 Fresenius Kabi Company Information
  21. 7.4.2 Fresenius Kabi Business Overview
  22. 7.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
  24. 7.4.5 Fresenius Kabi Recent Developments
  25. 7.5 Rovi
  26. 7.5.1 Rovi Company Information
  27. 7.5.2 Rovi Business Overview
  28. 7.5.3 Rovi Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Rovi Enoxaparin Sodium Product Portfolio
  30. 7.5.5 Rovi Recent Developments
  31. 7.6 Amphastar
  32. 7.6.1 Amphastar Company Information
  33. 7.6.2 Amphastar Business Overview
  34. 7.6.3 Amphastar Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Amphastar Enoxaparin Sodium Product Portfolio
  36. 7.6.5 Amphastar Recent Developments
  37. 7.7 Nanjing King-friend
  38. 7.7.1 Nanjing King-friend Company Information
  39. 7.7.2 Nanjing King-friend Business Overview
  40. 7.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
  42. 7.7.5 Nanjing King-friend Recent Developments
  43. 7.8 Sandoz
  44. 7.8.1 Sandoz Company Information
  45. 7.8.2 Sandoz Business Overview
  46. 7.8.3 Sandoz Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sandoz Enoxaparin Sodium Product Portfolio
  48. 7.8.5 Sandoz Recent Developments
  49. 7.9 Apotex
  50. 7.9.1 Apotex Company Information
  51. 7.9.2 Apotex Business Overview
  52. 7.9.3 Apotex Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Apotex Enoxaparin Sodium Product Portfolio
  54. 7.9.5 Apotex Recent Developments
  55. 7.10 Hangzhou Jiuyuan Gene Engineering
  56. 7.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
  57. 7.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  58. 7.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
  60. 7.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  61. 7.11 Cipla
  62. 7.11.1 Cipla Company Information
  63. 7.11.2 Cipla Business Overview
  64. 7.11.3 Cipla Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Cipla Enoxaparin Sodium Product Portfolio
  66. 7.11.5 Cipla Recent Developments
  67. 7.12 Taj Pharma
  68. 7.12.1 Taj Pharma Company Information
  69. 7.12.2 Taj Pharma Business Overview
  70. 7.12.3 Taj Pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
  72. 7.12.5 Taj Pharma Recent Developments
  73. 7.13 Chengdu Baiyu Pharmaceutical
  74. 7.13.1 Chengdu Baiyu Pharmaceutical Company Information
  75. 7.13.2 Chengdu Baiyu Pharmaceutical Business Overview
  76. 7.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
  78. 7.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
  79. 7.14 Suzhou Erye Pharmaceutical
  80. 7.14.1 Suzhou Erye Pharmaceutical Company Information
  81. 7.14.2 Suzhou Erye Pharmaceutical Business Overview
  82. 7.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
  84. 7.14.5 Suzhou Erye Pharmaceutical Recent Developments
  85. 7.15 Changzhou Qianhong Bio-pharma
  86. 7.15.1 Changzhou Qianhong Bio-pharma Company Information
  87. 7.15.2 Changzhou Qianhong Bio-pharma Business Overview
  88. 7.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
  90. 7.15.5 Changzhou Qianhong Bio-pharma Recent Developments
  91. 7.16 Hebei Changshan Biochemical Pharmaceutical
  92. 7.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  93. 7.16.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  94. 7.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
  96. 7.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  97. 7.17 Beijing SL Pharmaceutical
  98. 7.17.1 Beijing SL Pharmaceutical Company Information
  99. 7.17.2 Beijing SL Pharmaceutical Business Overview
  100. 7.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
  102. 7.17.5 Beijing SL Pharmaceutical Recent Developments
  103. 7.18 Huadong Medicine
  104. 7.18.1 Huadong Medicine Company Information
  105. 7.18.2 Huadong Medicine Business Overview
  106. 7.18.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
  108. 7.18.5 Huadong Medicine Recent Developments
  109. 7.19 Bharat Serums
  110. 7.19.1 Bharat Serums Company Information
  111. 7.19.2 Bharat Serums Business Overview
  112. 7.19.3 Bharat Serums Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
  114. 7.19.5 Bharat Serums Recent Developments
  115. 7.20 INTAS
  116. 7.20.1 INTAS Company Information
  117. 7.20.2 INTAS Business Overview
  118. 7.20.3 INTAS Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 INTAS Enoxaparin Sodium Product Portfolio
  120. 7.20.5 INTAS Recent Developments
  121. 7.21 LUPIN
  122. 7.21.1 LUPIN Company Information
  123. 7.21.2 LUPIN Business Overview
  124. 7.21.3 LUPIN Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 LUPIN Enoxaparin Sodium Product Portfolio
  126. 7.21.5 LUPIN Recent Developments
  127. 7.22 Troikaa Pharmaceuticals
  128. 7.22.1 Troikaa Pharmaceuticals Company Information
  129. 7.22.2 Troikaa Pharmaceuticals Business Overview
  130. 7.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
  132. 7.22.5 Troikaa Pharmaceuticals Recent Developments
  133. 7.23 Aristopharma
  134. 7.23.1 Aristopharma Company Information
  135. 7.23.2 Aristopharma Business Overview
  136. 7.23.3 Aristopharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
  138. 7.23.5 Aristopharma Recent Developments
  139. 7.24 Fosun Pharma
  140. 7.24.1 Fosun Pharma Company Information
  141. 7.24.2 Fosun Pharma Business Overview
  142. 7.24.3 Fosun Pharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
  144. 7.24.5 Fosun Pharma Recent Developments
  145. 7.25 SciencePharma
  146. 7.25.1 SciencePharma Company Information
  147. 7.25.2 SciencePharma Business Overview
  148. 7.25.3 SciencePharma Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
  150. 7.25.5 SciencePharma Recent Developments
  151. 7.26 PISA
  152. 7.26.1 PISA Company Information
  153. 7.26.2 PISA Business Overview
  154. 7.26.3 PISA Enoxaparin Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 PISA Enoxaparin Sodium Product Portfolio
  156. 7.26.5 PISA Recent Developments
8 North America
  1. 8.1 North America Enoxaparin Sodium Market Size by Type
  2. 8.1.1 North America Enoxaparin Sodium Revenue by Type (2021-2032)
  3. 8.1.2 North America Enoxaparin Sodium Sales by Type (2021-2032)
  4. 8.1.3 North America Enoxaparin Sodium Price by Type (2021-2032)
  5. 8.2 North America Enoxaparin Sodium Market Size by Application
  6. 8.2.1 North America Enoxaparin Sodium Revenue by Application (2021-2032)
  7. 8.2.2 North America Enoxaparin Sodium Sales by Application (2021-2032)
  8. 8.2.3 North America Enoxaparin Sodium Price by Application (2021-2032)
  9. 8.3 North America Enoxaparin Sodium Market Size by Country
  10. 8.3.1 North America Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Enoxaparin Sodium Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Enoxaparin Sodium Market Size by Type
  2. 9.1.1 Europe Enoxaparin Sodium Revenue by Type (2021-2032)
  3. 9.1.2 Europe Enoxaparin Sodium Sales by Type (2021-2032)
  4. 9.1.3 Europe Enoxaparin Sodium Price by Type (2021-2032)
  5. 9.2 Europe Enoxaparin Sodium Market Size by Application
  6. 9.2.1 Europe Enoxaparin Sodium Revenue by Application (2021-2032)
  7. 9.2.2 Europe Enoxaparin Sodium Sales by Application (2021-2032)
  8. 9.2.3 Europe Enoxaparin Sodium Price by Application (2021-2032)
  9. 9.3 Europe Enoxaparin Sodium Market Size by Country
  10. 9.3.1 Europe Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Enoxaparin Sodium Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Enoxaparin Sodium Market Size by Type
  2. 10.1.1 China Enoxaparin Sodium Revenue by Type (2021-2032)
  3. 10.1.2 China Enoxaparin Sodium Sales by Type (2021-2032)
  4. 10.1.3 China Enoxaparin Sodium Price by Type (2021-2032)
  5. 10.2 China Enoxaparin Sodium Market Size by Application
  6. 10.2.1 China Enoxaparin Sodium Revenue by Application (2021-2032)
  7. 10.2.2 China Enoxaparin Sodium Sales by Application (2021-2032)
  8. 10.2.3 China Enoxaparin Sodium Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enoxaparin Sodium Market Size by Type
  2. 11.1.1 Asia Enoxaparin Sodium Revenue by Type (2021-2032)
  3. 11.1.2 Asia Enoxaparin Sodium Sales by Type (2021-2032)
  4. 11.1.3 Asia Enoxaparin Sodium Price by Type (2021-2032)
  5. 11.2 Asia Enoxaparin Sodium Market Size by Application
  6. 11.2.1 Asia Enoxaparin Sodium Revenue by Application (2021-2032)
  7. 11.2.2 Asia Enoxaparin Sodium Sales by Application (2021-2032)
  8. 11.2.3 Asia Enoxaparin Sodium Price by Application (2021-2032)
  9. 11.3 Asia Enoxaparin Sodium Market Size by Country
  10. 11.3.1 Asia Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Enoxaparin Sodium Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enoxaparin Sodium Market Size by Type
  2. 12.1.1 SAMEA Enoxaparin Sodium Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Enoxaparin Sodium Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Enoxaparin Sodium Price by Type (2021-2032)
  5. 12.2 SAMEA Enoxaparin Sodium Market Size by Application
  6. 12.2.1 SAMEA Enoxaparin Sodium Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Enoxaparin Sodium Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Enoxaparin Sodium Price by Application (2021-2032)
  9. 12.3 SAMEA Enoxaparin Sodium Market Size by Country
  10. 12.3.1 SAMEA Enoxaparin Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Enoxaparin Sodium Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Enoxaparin Sodium Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Enoxaparin Sodium Value Chain Analysis
  2. 13.1.1 Enoxaparin Sodium Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Enoxaparin Sodium Production Mode & Process
  6. 13.2 Enoxaparin Sodium Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Enoxaparin Sodium Distributors
  9. 13.2.3 Enoxaparin Sodium Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst